PreventionGenetics
PreventionGenetics is a CAP-accredited, CLIA-certified clinical genetic testing laboratory in Marshfield, Wisconsin, serving healthcare professionals with whole genome, whole exome, and targeted gene panel tests across 6,000+ clinically relevant genes. It operates as a wholly owned subsidiary of Exact Sciences Corporation.
- Company typePrivate
- Founded2004
- HeadquartersMarshfield, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What PreventionGenetics does
PreventionGenetics is a clinical genetic testing laboratory founded in 2004 by Dr. James Weber and headquartered at 3800 S. Business Park Ave., Marshfield, Wisconsin. The company operates a CAP-accredited, CLIA-certified laboratory and offers three core testing modalities: PGnome® whole genome sequencing, PGxome® whole exome sequencing, and PGmax™ targeted gene panels, covering more than 6,000 clinically relevant genes. The company is a wholly owned subsidiary of Exact Sciences Corporation (NASDAQ: EXAS).
The company serves healthcare professionals — primarily physicians and genetic counselors — who order tests through the myPrevent online portal. Sample collection kits are shipped directly to patients' homes, and expert-reviewed genetic reports are returned to the ordering clinician for use in patient diagnosis and care planning, particularly for rare disease and genetic disorder cases. The company supports more than 240 clinical trials or research projects and processes 100,000+ cases annually with greater than 99% CAP proficiency testing scores.
Revenue is generated through clinical genetic testing services billed primarily through insurance, with PreventionGenetics maintaining in-network provider status with major commercial payers (Aetna, Anthem, Cigna, Humana, UnitedHealthcare) and enrollment in all 50 state Medicaid plans. The company is investing in AI-enabled variant curation through a partnership with the AWS Generative AI Innovation Center, using Amazon Bedrock large language models and Amazon Textract to automate literature search and evidence extraction, reportedly reducing research times for variant analysis by 30%.
PreventionGenetics firmographics
Firmographics- Name
- PreventionGenetics
- Legal name
- PreventionGenetics LLC
- Website
- https://preventiongenetics.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- PreventionGenetics is a CAP-accredited, CLIA-certified clinical genetic testing laboratory in Marshfield, Wisconsin, serving healthcare professionals with whole genome, whole exome, and targeted gene panel tests across 6,000+ clinically relevant genes. It operates as a wholly owned subsidiary of Exact Sciences Corporation.
- Ownership category
- akta.pro rank
PreventionGenetics industry classification
Industry- Product category
- Clinical Genetic Testing / Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Genetic & Prenatal Testing Laboratories (HLAFAMAH)
- akta.pro secondary industries
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)
Keywords
Where PreventionGenetics is headquartered
LocationHeadquarters
- HQ city
- Marshfield
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
PreventionGenetics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Clinical Genetic Testing Services: PreventionGenetics generates revenue through providing genetic testing services to healthcare professionals. Tests are ordered online through myPrevent platform, sample collection kits are shipped to patients, and expert-reviewed genetic reports are delivered to clinicians for patient care planning. The company is an in-network provider with major health insurers including Aetna, Anthem, Cigna, Humana, and UnitedHealthcare, and is enrolled in all 50 state Medicaid plans.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
PreventionGenetics product offering
Product offeringCore offering
PreventionGenetics operates a CAP-accredited and CLIA-certified clinical genetic testing laboratory providing next-generation sequencing-based diagnostic services to healthcare professionals. The company offers whole genome sequencing (PGnome®), whole exome sequencing (PGxome®), and targeted gene panels (PGmax™) covering 6,000+ clinically relevant genes, with orders placed online through the myPrevent portal, sample kits shipped directly to patients, and expert-reviewed genetic reports returned to clinicians for care planning.
Product overview
PreventionGenetics is a genetic testing laboratory offering a multi-tiered portfolio of products. The core offerings include three main testing modalities: PGnome® Tests (whole genome sequencing/WGS), PGxome® Tests (whole exome sequencing/WES), and PGmax™ Panels (targeted gene panels). These products are supported by a comprehensive Test Catalog that enables healthcare professionals to explore testing options for nearly 6,000 clinically relevant genes. The company also provides an online ordering platform called myPrevent for managing orders. All tests are performed in PreventionGenetics' CAP-accredited and CLIA-certified laboratory in Marshfield, Wisconsin, and the company serves as a wholly owned subsidiary of Exact Sciences Corp.
Differentiator
Problem solved
Functional benefit
Brands
- PGnome®: Whole genome sequencing (WGS) tests for comprehensive genetic analysis
- PGxome®
- PGmax™
Products and services
- PGnome® Tests Whole genome sequencing (WGS) tests that analyze the complete DNA sequence of an individual's genome, enabling comprehensive detection of genetic variants across all clinically relevant genes. Performed in the CAP-accredited and CLIA-certified Marshfield, Wisconsin laboratory for healthcare professionals ordering diagnostic tests.
- PGxome® Tests Whole exome sequencing (WES) tests that sequence the protein-coding regions of the genome, focusing on variants most likely to affect protein function and disease phenotype. Targeted at healthcare professionals diagnosing genetic disorders in patients.
- PGmax™ Panels Targeted gene panel tests that analyze specific sets of genes associated with particular conditions or clinical indications, offering a more focused and cost-efficient alternative to whole genome or exome sequencing. Used by healthcare professionals for condition-specific genetic analysis.
- Test Catalog Comprehensive searchable catalog of genetic tests covering nearly all clinically relevant genes, enabling healthcare professionals to discover and select appropriate testing options for their patients. Supports ordering selection across the PGnome®, PGxome®, and PGmax™ test families.
- myPrevent Online Ordering Platform Online ordering and order management platform that allows healthcare professionals to place genetic testing orders and manage all orders in a single dashboard, streamlining the testing workflow from order through sample shipment to result delivery.
Quantifiable outcome
- 30% reduction in research times through AI-powered variant curation (via Amazon Bedrock partnership)
Companies that use PreventionGenetics
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
PreventionGenetics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
PreventionGenetics partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- AWS Generative AI Innovation CentercorePreventionGenetics collaborated with the AWS Generative AI Innovation Center to build a Variant Curation Accelerator proof of concept in six weeks. The solution uses Amazon Bedrock with large language models to search relevant papers, extract findings via Amazon Textract, and present results for human review, achieving a 30 percent reduction in research times for variant analysis.
- AmazoncorePreventionGenetics utilizes Amazon Bedrock for AI-powered variant curation, enabling automated genetic variant analysis using large language models to accelerate diagnostic insights for patients with rare diseases.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
PreventionGenetics competitors and assessment
Company assessmentMarket position
Strengths5 records
Competitive moat4 records
Key highlights7 records
Customer concentration
PreventionGenetics social profiles
Digital presencePreventionGenetics compliance and trust
Trust signalCompliance3 records
PreventionGenetics financial estimates
Financial estimateRevenue estimate
Valuation estimate
PreventionGenetics leadership team
Management profileNumber of profiles
Profiles1 record
PreventionGenetics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PreventionGenetics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PreventionGenetics
What does PreventionGenetics do?
PreventionGenetics operates a CAP-accredited and CLIA-certified clinical genetic testing laboratory providing next-generation sequencing-based diagnostic services to healthcare professionals. The company offers whole genome sequencing (PGnome®), whole exome sequencing (PGxome®), and targeted gene panels (PGmax™) covering 6,000+ clinically relevant genes, with orders placed online through the myPrevent portal, sample kits shipped directly to patients, and expert-reviewed genetic reports returned to clinicians for care planning.
Is PreventionGenetics a public or private company?
PreventionGenetics is a private company. It is classified as corporate owned and is currently operating.
When was PreventionGenetics founded?
PreventionGenetics was founded in 2004. It employs 101 to 250 people.
Where is PreventionGenetics based?
PreventionGenetics is headquartered in Marshfield, United States, in the North America region.
How does PreventionGenetics make money?
One revenue line is on record: clinical Genetic Testing Services.
Does PreventionGenetics have an API?
No public API is recorded for PreventionGenetics.
What industry is PreventionGenetics in?
PreventionGenetics's product category is Clinical Genetic Testing / Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAH, Genetic & Prenatal Testing Laboratories, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 621511 and its SIC code is 8071.